Volume 141, Issue 1, Pages 150-156 (July 2011) Pancreatitis, Pancreatic, and Thyroid Cancer With Glucagon-Like Peptide-1–Based Therapies Michael Elashoff, Aleksey V. Matveyenko, Belinda Gier, Robert Elashoff, Peter C. Butler Gastroenterology Volume 141, Issue 1, Pages 150-156 (July 2011) DOI: 10.1053/j.gastro.2011.02.018 Copyright © 2011 AGA Institute Terms and Conditions
Figure 1 Odds ratio of test vs control events for exenatide, sitagliptin, and other therapies. The odds ratio of an adverse report of pancreatitis, pancreatic and thyroid cancer, or any cancer associated with exenatide and/or sitagliptin therapy vs other therapies. Gastroenterology 2011 141, 150-156DOI: (10.1053/j.gastro.2011.02.018) Copyright © 2011 AGA Institute Terms and Conditions